Introduction: Aorto-iliac occlusive disease can cause disabling symptoms and Trans-Atlantic Inter-Society Consensus (TASC II) has recommended the treatment options for varying severity of the disease. In the TASC II article, an increasing interest for laparoscopic aorto-ilio-femoral surgery was noted.

Aim: To review the literature on the minimally invasive interventions currently used in aorto-iliac occlusive disease with a focus on laparoscopic aortic surgery.

Methods: Medline search and hand search of references from relevant articles to describe the current management options for aorto-iliac occlusive disease.

Conclusion: Laparoscopic aorto-femoral surgery is a therapeutic option for most TASC C and D lesions.

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLE.0b013e3181a6f349DOI Listing

Publication Analysis

Top Keywords

aorto-iliac occlusive
16
occlusive disease
12
minimally invasive
8
invasive interventions
8
aorto-iliac
4
interventions aorto-iliac
4
occlusive
4
disease
4
disease introduction
4
introduction aorto-iliac
4

Similar Publications

Introduction: In 2015, Society for Vascular Surgery guidelines on claudication management were released spanning optimal medical management, procedural, and post-procedure recommendations. Uptake of guidelines and changes to clinical practice over time remain unknown. This study hypothesized that guideline aligned practice increased after guideline release.

View Article and Find Full Text PDF

In-hospital outcomes of acute aortic occlusion treated by endovascular intervention: A single center study.

Vascular

December 2024

Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, Harapan Kita National Cardiovascular Center, Jakarta, Indonesia.

Background: Endovascular intervention by means of thrombolysis is emerging as a promising management of Acute Aortic Occlusion (AAO). This study aims to evaluate the outcomes of endovascular thrombectomy for AAO cases in a single-center tertiary hospital in Indonesia.

Methods: We review retrospectively AAO patients treated by Rheolytic thrombectomy ± stenting or TEVAR at our referral center from 2011 to 2024.

View Article and Find Full Text PDF
Article Synopsis
  • Treating atherosclerotic occlusive disease in the infrarenal aorta is challenging, with traditional open surgery posing high risks for morbidity and mortality.
  • The American College of Cardiology (ACC)/American Heart Association (AHA) classification helps assess patient risk, especially benefiting high-risk patients through advancements in endovascular technologies.
  • Minimally invasive methods, such as chimney-CERAB, have been effectively used to treat patients with aortoiliac occlusive disease while preserving key blood vessels like the inferior mesenteric artery.
View Article and Find Full Text PDF

: In recent years, manufacturers have developed new low-profile stent grafts to allow endovascular treatment of abdominal aortic aneurysms (AAA) in patients with small access vessels. We evaluated the early and mid-term outcomes of the Incraft (Cordis Corp, Bridgewater, NJ, USA) ultra-low profile endograft implantation in a high-volume single center. : Between 2014 and 2023, 133 consecutive endovascular aneurysm repair (EVAR) procedures performed using the Incraft endograft were recorded in a prospective database.

View Article and Find Full Text PDF

Introduction: Peripheral arterial disease (PAD) is a critical concern, particularly in the context of an aging population and escalating risk factors such as diabetes, hypertension, and smoking. PAD leads to significant morbidity and disability, imposing considerable healthcare and economic burdens. A detailed understanding of the functional outcomes of revascularization is essential as it influences the choice of therapeutic strategies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!